Pegfilgrastim vs. filgrastim in reducing risk of febrile neutropenia.
Publication
, Conference
Lyman, GH; Bernal, M; Badamgarav, E; Pinto, L; Dubois, RW
Published in: BLOOD
2003
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
2003
Volume
102
Issue
11
Start / End Page
170B / 171B
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Bernal, M., Badamgarav, E., Pinto, L., & Dubois, R. W. (2003). Pegfilgrastim vs. filgrastim in reducing risk of febrile neutropenia. In BLOOD (Vol. 102, pp. 170B-171B).
Lyman, G. H., M. Bernal, E. Badamgarav, L. Pinto, and R. W. Dubois. “Pegfilgrastim vs. filgrastim in reducing risk of febrile neutropenia.” In BLOOD, 102:170B-171B, 2003.
Lyman GH, Bernal M, Badamgarav E, Pinto L, Dubois RW. Pegfilgrastim vs. filgrastim in reducing risk of febrile neutropenia. In: BLOOD. 2003. p. 170B-171B.
Lyman, G. H., et al. “Pegfilgrastim vs. filgrastim in reducing risk of febrile neutropenia.” BLOOD, vol. 102, no. 11, 2003, pp. 170B-171B.
Lyman GH, Bernal M, Badamgarav E, Pinto L, Dubois RW. Pegfilgrastim vs. filgrastim in reducing risk of febrile neutropenia. BLOOD. 2003. p. 170B-171B.
Published In
BLOOD
ISSN
0006-4971
Publication Date
2003
Volume
102
Issue
11
Start / End Page
170B / 171B
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology